Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Manetta

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|September 21, 2000
University of California, Irvine, College of MedicineA Manetta
Gynecologic Oncology|July 1, 1991
Bleomycin, ifosfamide, and cisplatin (BIP) in patients with recurrent and advanced cervical cancerA Manetta
Current Oncology Reports|December 21, 2000
In vitro chemosensitivity testing and mechanisms of drug resistanceK Tewari, A Manetta
Contributions to Gynecology and Obstetrics|January 1, 1994
Use of the extreme drug resistance assay to evaluate mechanisms of resistance in ovarian cancer: taxol resistance and MDR-1 expressionJ P Fruehauf, A Manetta
Current Opinion in Obstetrics & Gynecology|August 1, 1993
Benign and malignant pathology of the cervix, including screeningS Y Liao, A Manetta
The American Journal of Clinical Nutrition|December 1, 1995
Prevention of cervical intraepithelial neoplasia and cervical cancerF L Meyskens, A Manetta
Health & Social Work|September 4, 2001
Ethical issues in the social worker's role in physician-assisted suicideA A Manetta, J G Wells
Academic Medicine : Journal of the Association of American Medical Colleges|March 4, 1998
Familiar SPs may affect students performances on SP examsA Manetta, E M Lewis, S Ahearn
Gynecologic Oncology|July 1, 1997
Hexamethylmelamine as a single second-line agent in ovarian cancer: follow-up report and review of the literatureA Manetta, K Tewari, E S Podczaski
American Journal of Clinical Oncology|April 1, 1995
A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group studyA Manetta, J A Blessing, K Y Look
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Academic Medicine : Journal of the Association of American Medical Colleges|September 21, 2000
University of California, Irvine, College of MedicineA Manetta
Gynecologic Oncology|July 1, 1991
Bleomycin, ifosfamide, and cisplatin (BIP) in patients with recurrent and advanced cervical cancerA Manetta
Current Oncology Reports|December 21, 2000
In vitro chemosensitivity testing and mechanisms of drug resistanceK Tewari, A Manetta
Contributions to Gynecology and Obstetrics|January 1, 1994
Use of the extreme drug resistance assay to evaluate mechanisms of resistance in ovarian cancer: taxol resistance and MDR-1 expressionJ P Fruehauf, A Manetta
Current Opinion in Obstetrics & Gynecology|August 1, 1993
Benign and malignant pathology of the cervix, including screeningS Y Liao, A Manetta
The American Journal of Clinical Nutrition|December 1, 1995
Prevention of cervical intraepithelial neoplasia and cervical cancerF L Meyskens, A Manetta
Health & Social Work|September 4, 2001
Ethical issues in the social worker's role in physician-assisted suicideA A Manetta, J G Wells
Academic Medicine : Journal of the Association of American Medical Colleges|March 4, 1998
Familiar SPs may affect students performances on SP examsA Manetta, E M Lewis, S Ahearn
Gynecologic Oncology|July 1, 1997
Hexamethylmelamine as a single second-line agent in ovarian cancer: follow-up report and review of the literatureA Manetta, K Tewari, E S Podczaski
American Journal of Clinical Oncology|April 1, 1995
A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group studyA Manetta, J A Blessing, K Y Look
Pageof 11